Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm of Breast (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03433560
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Who this might be right for
Breast Cancer FemaleBreast Neoplasm Female
Kyowa Kirin Korea Co., Ltd. 1,300
Not applicableUnknownNCT03920488
What this trial is testing

Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
European Institute of Oncology 264
Not applicableStudy completedNCT01043003
What this trial is testing

Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers

Who this might be right for
Breast CancerDuctal Breast Carcinoma in SituStage I Breast Cancer+4 more
City of Hope Medical Center 49
Not applicableStudy completedNCT05089903
What this trial is testing

Breast Cancer Outreach Among Primary Care Patients

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 24,680
Large-scale testing (Phase 3)Active Not RecruitingNCT05654623
What this trial is testing

Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer
Pfizer 624
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Not applicableLooking for participantsNCT07548762
What this trial is testing

Endoscopic Skin-Sparing vs. Conventional Mastectomy for Wound Complications in BC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 258
Not applicableEnded earlyNCT00595296
What this trial is testing

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Who this might be right for
Breast Cancer
Janssen Diagnostics, LLC 461
Not applicableStudy completedNCT01372527
What this trial is testing

Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT

Who this might be right for
Breast CancerColorectal CancerCervical Cancer
Massachusetts General Hospital 103,870
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05821686
What this trial is testing

Efficacy of Interleukin-2 in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Nova Scotia Health Authority 10
Testing effectiveness (Phase 2)Study completedNCT03213041
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Northwestern University 12
Very early researchStudy completedNCT00301041
What this trial is testing

Radiation Therapy in Treating Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Francisco 20
Early research (Phase 1)Active Not RecruitingNCT07457541
What this trial is testing

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Pancreas Cancer, MetastaticBreast Cancer (Locally Advanced or Metastatic)+1 more
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Not applicableStudy completedNCT06205394
What this trial is testing

Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study

Who this might be right for
Breast Carcinoma
Ohio State University Comprehensive Cancer Center 28
Not applicableUnknownNCT02181166
What this trial is testing

Diagnosis and Management of Myofascial Pain Syndrome in Women With Mastectomies

Who this might be right for
Breast CancerMyofascial Trigger Point
University of Sao Paulo 60
Testing effectiveness (Phase 2)WithdrawnNCT03794596
What this trial is testing

A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer

Who this might be right for
Breast Cancer
The Christie NHS Foundation Trust
Not applicableLooking for participantsNCT06970288
What this trial is testing

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

Who this might be right for
Breast Carcinoma
Ain Shams University 85
Not applicableStudy completedNCT00467727
What this trial is testing

Visibility of Lesion Characteristics With Phase Contrast Mammography

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06394661
What this trial is testing

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Who this might be right for
Breast Cancer
Henan Cancer Hospital 109
Testing effectiveness (Phase 2)UnknownNCT06341842
What this trial is testing

Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity

Who this might be right for
Breast Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 316
Next Page